SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

Share Price is delayed by 15 minutes
Get Live Data
4,612.00    26.00 (0.57%)
Bid:
4,612.00
Ask:
4,616.00
Spread: 4.00 (0.087%)
Market Cap: £16.81b
CCH Live PriceLast checked at - London Stock Exchange

Intraday Coca-Cola HBC Share Chart

Directorate Change

24 Jun 2015 09:06

RNS Number : 0649R
Coca-Cola HBC AG
24 June 2015
 



 

FOR IMMEDIATE RELEASE

 

Coca-Cola HBC AG

Appointment of new members of the Board of Directors and composition of the Committees of the Board of Directors of Coca-Cola HBC AG

 

 

Zug, Switzerland - 24 June 2015 - Coca-Cola HBC AG ("Coca-Cola HBC" or the "Company") announces today that Mrs. Olusola (Sola) David-Borha and Mrs. Alexandra Papalexopoulou were elected as non-executive members of the Board of Directors of Coca-Cola HBC (the "Board") by the Company's annual general meeting held on 23 June 2015 (the "AGM"), following the retirement from the Board of Mrs. Susan Kilsby and Mr. Christos Ioannou. The AGM further elected Mrs. Papalexopoulou to the Company's Remuneration Committee.

 

Following the AGM, the Board has appointed Mrs. David-Borhaas a member of the Audit Committee and Mrs. Papalexopoulou as a member of the Nomination Committee of Coca-Cola HBC, with effect from 24 June 2015. On the same date, Mr. Anastassis David and Mr. José Octavio Reyes retired from the Company's Nomination Committee and the members of the Nomination Committee are Sir Michael-Llewellyn-Smith (Chairman), Mr. Antonio D' Amato and Mrs. Alexandra Papalexopoulou.

 

The Board has also determined that Mrs. David-Borha and Mrs Papalexopoulou are independent in character and judgment. Consequently, the Board considers Mrs. David-Borha and Mrs Papalexopoulou to be independent for purposes of the UK Corporate Governance Code.

 

Aside from the information set out above, no further information is required to be disclosed pursuant to the UK Financial Conduct Authority's Listing Rule 9.6.13 and none of the new non-executive directors hold any interests in the shares of Coca-Cola HBC.

 

This announcement is made pursuant to Listing Rule 9.6.11.

 

Enquiries

 

Coca‑Cola HBC Group

Basak Kotler

Investor Relations Director

 

Tel: +41 41 726 0143

 basak.kotler@cchellenic.com

 

Eri Tziveli

Investor Relations Manager

Tel: +30 210 618 3133

 eri.tziveli@cchellenic.com

 

Nikos Efstathopoulos

Investor Relations Manager

Tel: +30 210 618 3260 

 nikos.efstathopoulos@cchellenic.com

 

 

International media contact:

StockWell Communications

Rob Morgan

Ben Ullmann

Anushka Mathew

Tel: +44 20 7240 2486

 robert.morgan@stockwellgroup.com

 ben.ullmann@stockwellgroup.com

 anushka.mathew@stockwellgroup.com

 

Greek media contact:

V+O Communications

Argyro Oikonomou

Tel: +30 211 7501219

 ao@vando.gr

 

About Coca‑Cola HBC

Coca-Cola HBC is the second-largest bottler of the brands of The Coca-Cola Company in terms of volume with sales of more than 2 billion unit cases. It has a broad geographic footprint with operations in 28 countries serving a population of approximately 590 million people. Coca-Cola HBC offers a diverse range of non-alcoholic ready to drink beverages in the sparkling, juice, water, sport, energy, tea and coffee categories. Coca-Cola HBC is committed to promoting sustainable development in order to create value for its business and for society. This includes providing products that meet the beverage needs of consumers, fostering an open and inclusive work environment, conducting its business in ways that protect and preserve the environment and contribute to the socio-economic development of the local communities.

 

Coca-Cola HBC has a premium listing on the London Stock Exchange (LSE: CCH) and its shares are listed on the Athens Exchange (ATHEX: EEE). Coca-Cola HBC is included in the Dow Jones Sustainability and FTSE4Good Indexes. For more information, please visit http://www.coca-colahellenic.com.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOALIFITRFISFIE
Date   Source Headline
22nd May 20263:30 pmRNSDirector/PDMR Shareholding
19th May 20263:15 pmRNSDirector/PDMR Shareholding
11th May 20269:00 amRNSDirector Declaration
8th May 20263:15 pmRNSComposition of the Board Committees
8th May 20263:10 pmRNSResult of AGM
7th May 20267:00 amRNSStrong volume drives Q1 sales growth
20th Apr 20263:15 pmRNSDirector/PDMR Shareholding
14th Apr 202612:15 pmRNSNotice of Results
2nd Apr 20267:00 amRNSNotice of AGM, changes to the BoD, dividend dates
1st Apr 20269:15 amRNSTransfer of treasury shares & total voting rights
31st Mar 202611:00 amRNSPublication of Final Terms
27th Mar 20262:45 pmRNSDirector/PDMR Shareholding
27th Mar 20262:15 pmRNSDirector/PDMR Shareholding
26th Mar 20266:18 pmRNSPricing of Issue of Notes
26th Mar 20269:05 amRNSLaunch of Issue of Notes
25th Mar 20261:36 pmRNSPublication of a Prospectus
20th Mar 202611:00 amRNSAnnual Financial Report
19th Mar 20264:55 pmRNSDirector/PDMR Shareholding
19th Mar 20264:45 pmRNSDirector/PDMR Shareholding
18th Mar 20264:15 pmRNSDirector/PDMR Shareholding
18th Mar 202611:35 amRNSDirector/PDMR Shareholding
26th Feb 202611:30 amRNSDirector/PDMR Shareholding
25th Feb 20269:20 amRNSDirector/PDMR Shareholding
24th Feb 20264:55 pmRNSDirector/PDMR Shareholding
24th Feb 20264:50 pmRNSDirector/PDMR Shareholding
23rd Feb 20264:40 pmRNSDirector/PDMR Shareholding
23rd Feb 20264:35 pmRNSDirector/PDMR Shareholding
18th Feb 20264:50 pmRNSDirector/PDMR Shareholding
18th Feb 20264:45 pmRNSDirector/PDMR Shareholding
18th Feb 20264:00 pmRNSDirector/PDMR Shareholding
17th Feb 20263:35 pmRNSDirector/PDMR Shareholding
17th Feb 20263:30 pmRNSDirector/PDMR Shareholding
16th Feb 20262:40 pmRNSDirector/PDMR Shareholding
16th Feb 20262:35 pmRNSDirector/PDMR Shareholding
13th Feb 202610:30 amRNSDirector/PDMR Shareholding
12th Feb 20263:45 pmRNSDirector/PDMR Shareholding
12th Feb 20261:15 pmRNSDirector/PDMR Shareholding
10th Feb 20267:00 amRNSStrong execution and financial performance in 2025
2nd Feb 202610:00 amRNSTransfer of treasury shares & total voting rights
19th Jan 20264:00 pmRNSDirector/PDMR Shareholding
19th Jan 20262:20 pmRNSResult of Extraordinary General Meeting
13th Jan 202611:00 amRNSNotice of Results
5th Jan 202610:00 amRNSDirector/PDMR Shareholding
23rd Dec 20252:45 pmRNSDirector/PDMR Shareholding
23rd Dec 20252:45 pmRNSDirector/PDMR Shareholding
22nd Dec 20252:15 pmRNSDirector/PDMR Shareholding
22nd Dec 20252:15 pmRNSDirector/PDMR Shareholding
18th Dec 20255:00 pmRNSDirector/PDMR Shareholding
18th Dec 20255:00 pmRNSDirector/PDMR Shareholding
18th Dec 20253:15 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.